Clinical Trial Update: Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections [Phase 2]

View source ↗

Summary

A Phase 2 multicenter, double-blind trial comparing NXL104/Ceftazidime + Metronidazole versus Meropenem for complicated intra-abdominal infections. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• Meropenem (Meropenem)
• NXL104 (NXL104)
• ceftazidime (ceftazidime)

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-abdominal Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-07-03